-
GOT1 Inhibition by Ziprasidone Disrupts PDAC Redox Homeostas
2026-06-18
The referenced study demonstrates that ziprasidone is a novel non-competitive inhibitor of GOT1, effectively suppressing pancreatic ductal adenocarcinoma (PDAC) proliferation by reprogramming glutamine metabolism and disrupting intracellular redox balance. These findings highlight the therapeutic potential of targeting GOT1-mediated metabolic pathways in PDAC.
-
Trelagliptin Enhances Osteoblastic Differentiation via RUNX2
2026-06-18
The referenced study demonstrates that Trelagliptin, a DPP-4 inhibitor, promotes osteoblastic differentiation in MC3T3-E1 cells by upregulating RUNX2 through AMPK activation. These findings suggest a potential therapeutic avenue for osteoporosis and provide a mechanistic basis for further translational research.
-
Semi-Automated Screening Reveals Fast-Dissociating V5 Tag An
2026-06-17
Miyoshi et al. introduce a semi-automated single-molecule microscopy workflow to identify fast-dissociating, highly specific monoclonal antibodies directly from hybridoma cultures. Their approach advances the toolbox for multiplexed protein imaging and enables new insight into transient molecular processes using epitope tag systems like the V5 tag.
-
Spermine Tetrahydrochloride: Structural Biology and NMDA Res
2026-06-17
Explore the advanced structural and neurobiological applications of spermine tetrahydrochloride, a key polyamine in protein crystallization and NMDA receptor research. This article reveals new insights into its mechanisms, protocol parameters, and practical assay design.
-
Protease Inhibitor Cocktail: Precision Protein Degradation P
2026-06-16
The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO empowers researchers to halt endogenous protease activity during cell lysis and protein extraction, preserving molecular integrity in critical assays. Explore optimized workflows, evidence-based troubleshooting, and insights from frontier cancer research that highlight the cocktail's essential role in reproducible protein analyses.
-
Differential Roles of Chuanxiong Cortex and Pith in CHD Ther
2026-06-16
This study uses advanced SPME-GC×GC-MS and network pharmacology to dissect the distinct bioactive profiles of Ligusticum chuanxiong's rhizome cortex and pith in coronary heart disease (CHD) prevention. The identification of Fenipentol (1-Phenyl-1-pentanol) as a cortex-specific component highlights new molecular targets for cardiovascular and gastrointestinal research.
-
Phosbind Acrylamide: Precision SDS-PAGE for Phosphorylation
2026-06-15
Phosbind Acrylamide unlocks high-resolution, antibody-free detection of protein phosphorylation states, streamlining workflows in plant signaling and kinase pathway research. Its MnCl2-based phosphate-binding chemistry enables robust differentiation of phosphorylated proteins, empowering advanced studies in stress adaptation and cellular signaling.
-
Natural Compounds Target SARS-CoV-2 Protease: Docking Study
2026-06-15
This study applies molecular docking and dynamics to evaluate repurposed natural compounds, particularly vitamins, as inhibitors of the SARS-CoV-2 main protease (3CLpro) and spike protein RBD. The results reveal key compounds with strong binding potential, informing future antiviral therapeutics research and highlighting the utility of structure-guided drug discovery.
-
Enhancing Cell Proliferation Assays with Murine Recombinant
2026-06-14
Murine recombinant PDGF-BB unlocks high-fidelity, reproducible control of cell proliferation—vital in vascular remodeling and metabolic reprogramming research. This article delivers actionable protocols, troubleshooting insights, and evidence-based workflow improvements that empower advanced studies in smooth muscle biology and pulmonary hypertension.
-
Mc-Val-Cit-PABC-PNP: Technical Parameters for ADC Linker Use
2026-06-13
Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for antibody-drug conjugate (ADC) workflows requiring selective lysosomal payload release. It is optimal for organic solvent-based research protocols but unsuitable for aqueous, diagnostic, or therapeutic applications.
-
Pyridostigmine Suppresses Placental Necroptosis in Preeclamp
2026-06-12
This study demonstrates that pyridostigmine attenuates placental necroptosis and mitigates preeclampsia-like symptoms in a rat model by enhancing non-neuronal cholinergic signaling through α7 nicotinic acetylcholine receptors. The findings highlight the potential of targeting nicotinic receptor pathways for therapeutic intervention in placental ischemia-driven complications.
-
Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Linker Use
2026-06-12
Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker designed for targeted drug delivery research, enabling controlled intracellular release of cytotoxic payloads in antibody-drug conjugate (ADC) workflows. It is optimized for use in organic solvents and is not recommended for aqueous, diagnostic, or therapeutic applications.
-
RIPA Lysis Buffer Strong: Optimized Workflows for Protein Ex
2026-06-11
RIPA Lysis Buffer (Strong, without inhibitors) delivers exceptional protein extraction from even challenging animal cell and tissue samples, supporting high-quality results in immunological assays. Its customizable inhibitor strategy and robust detergent action make it the preferred choice for advanced workflows requiring flexibility and reliability.
-
Applied Use of LY2109761: TGF-β Receptor Dual Inhibition in
2026-06-11
LY2109761, a selective TGF-β receptor type I and II dual inhibitor, enables precision modulation of cancer cell plasticity, tumorigenesis, and radiosensitivity. This guide translates mechanistic insights and recent breakthroughs into actionable experimental workflows, troubleshooting strategies, and practical protocol enhancements.
-
HATU in Peptide Synthesis Chemistry: Workflows & Troubleshoo
2026-06-10
HATU’s unique reactivity profile makes it a premier choice for high-yield amide and ester bond formation in advanced peptide synthesis chemistry. This article combines real-world protocols, comparative advantages, and troubleshooting tips to help researchers leverage HATU for selective inhibitor design and challenging coupling reactions.